Cargando…

Structure-based docking, pharmacokinetic evaluation, and molecular dynamics-guided evaluation of traditional formulation against SARS-CoV-2 spike protein receptor bind domain and ACE2 receptor complex

There is an urgent need for reliable cure and preventive measures in this hour of the outbreak of SARS-CoV-2. Siddha- and Ayurvedic-based classical formulations have antiviral properties and great potential therapeutic choice in this pandemic situation. In the current study, in silico-based analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	kumar, B. Harish, Manandhar, Suman, Mehta, Chetan H., Nayak, Usha Y., Pai, K. Sreedhara Ranganath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Versita 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522134/ https://www.ncbi.nlm.nih.gov/pubmed/34690412 http://dx.doi.org/10.1007/s11696-021-01917-z

Ejemplares similares

Molecular dynamics and structure-based virtual screening and identification of natural compounds as Wnt signaling modulators: possible therapeutics for Alzheimer’s disease
por: Manandhar, Suman, et al.
Publicado: (2022)

Identification of phytochemical as a dual inhibitor of PI3K and mTOR: a structure-based computational approach
por: Kumar, B. Harish, et al.
Publicado: (2022)

Role of GSK-3β Inhibitors: New Promises and Opportunities for Alzheimer’s Disease
por: Shri, Suggala Ramya, et al.
Publicado: (2023)

Identification of novel TMPRSS2 inhibitors against SARS-CoV-2 infection: a structure-based virtual screening and molecular dynamics study
por: Manandhar, Suman, et al.
Publicado: (2022)

Comparative molecular docking analysis of the SARS CoV-2 Spike glycoprotein with the human ACE-2 receptors and thrombin
por: Bhanu, Piyush, et al.
Publicado: (2020)

Docking Studies and Biological Activity of Fosinopril Analogs
por: Choudary, Jayant, et al.
Publicado: (2014)

Identification, virtual screening and molecular dynamic analysis of novel TMPRSS2 inhibitors from natural compound database as potential entry-blocking agents in SARS-CoV-2 therapy
por: Manandhar, Suman, et al.
Publicado: (2022)

Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
por: Zhao, Peng, et al.
Publicado: (2020)

Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
por: Zhao, Peng, et al.
Publicado: (2020)

Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer
por: Baby, Krishnaprasad, et al.
Publicado: (2023)

Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study
por: Sankhe, Runali, et al.
Publicado: (2021)

Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach
por: Aljindan, Reem Y., et al.
Publicado: (2021)

Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance
por: Maity, Swastika, et al.
Publicado: (2020)

Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
por: Calcagnile, Matteo, et al.
Publicado: (2021)

SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human ACE2 receptors
por: Mishra, Pushpendra Mani, et al.
Publicado: (2022)

Evaluation of Inhibitory Activity In Silico of In-House Thiomorpholine Compounds between the ACE2 Receptor and S1 Subunit of SARS-CoV-2 Spike
por: Vázquez-Valadez, Victor H., et al.
Publicado: (2021)

SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study
por: Baby, Krishnaprasad, et al.
Publicado: (2021)

Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2
por: Wang, Shunxin, et al.
Publicado: (2008)

Docking and QSAR of Aminothioureas at the SARS-CoV-2 S-Protein–Human ACE2 Receptor Interface
por: Płonka, Wojciech, et al.
Publicado: (2020)

Correlating the differences in the receptor binding domain of SARS-CoV-2 spike variants on their interactions with human ACE2 receptor
por: Mahalingam, Gokulnath, et al.
Publicado: (2023)

Sphingosine prevents binding of SARS–CoV-2 spike to its cellular receptor ACE2
por: Edwards, Michael J., et al.
Publicado: (2020)

Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors
por: Targosz-Korecka, Marta, et al.
Publicado: (2021)

Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike
por: Batista, Alex D., et al.
Publicado: (2022)

Design, development, drug-likeness, and molecular docking studies of novel piperidin-4-imine derivatives as antitubercular agents
por: Revathi, Rajappan, et al.
Publicado: (2015)

Molecular docking and in vitro analysis of peptides from Stolephorus indicus with ACE2
por: Usha Rani, Keshapaga, et al.
Publicado: (2023)

Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor
por: Durmaz, Bengül, et al.
Publicado: (2020)

Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding
por: Hoter, Abdullah, et al.
Publicado: (2022)

A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor
por: Souza, Pedro F.N., et al.
Publicado: (2020)

Screening of potential spike glycoprotein / ACE2 dual antagonists against COVID-19 in silico molecular docking
por: Yu, Ran, et al.
Publicado: (2022)

Atomistic insights into the binding of SARS-CoV-2 spike receptor binding domain with the human ACE2 receptor: The importance of residue 493
por: Carter, Camryn, et al.
Publicado: (2023)

Interaction Between the Spike Protein of Human Coronavirus NL63 and its Cellular Receptor ACE2
por: Pöhlmann, Stefan, et al.
Publicado: (2006)

Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2
por: Basu, Anamika, et al.
Publicado: (2020)

Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity
por: Chowdhury, Ratul, et al.
Publicado: (2020)

Coevolutionary forces shaping the fitness of SARS-CoV-2 spike glycoprotein against human receptor ACE2
por: Priya, Prerna, et al.
Publicado: (2021)

Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis
por: Ortega, Joseph Thomas, et al.
Publicado: (2020)

SARS CoV-2 Spike Protein in silico Interaction With ACE2 Receptors From Wild and Domestic Species
por: Rendon-Marin, Santiago, et al.
Publicado: (2021)

Millisecond dynamic of SARS‐CoV‐2 spike and its interaction with ACE2 receptor and small extracellular vesicles
por: Lim, Keesiang, et al.
Publicado: (2021)

Cryo-EM structures of SARS-CoV-2 BA.2-derived subvariants spike in complex with ACE2 receptor
por: Li, Yaning, et al.
Publicado: (2023)

On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2
por: Corrêa Giron, Carolina, et al.
Publicado: (2020)

Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2
por: Song, Wenfei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bhtjnbo2geu8tr5d6f50dq8vop